C4 Therapeutics, Inc. (CCCC)
NASDAQ: CCCC · Real-Time Price · USD
3.630
-0.050 (-1.36%)
At close: May 14, 2026, 4:00 PM EDT
3.648
+0.018 (0.50%)
After-hours: May 14, 2026, 6:40 PM EDT
C4 Therapeutics Market Cap
C4 Therapeutics has a market cap or net worth of $399.96 million as of May 14, 2026. Its market cap has increased by 256.50% in one year.
Market Cap
399.96M
Enterprise Value
192.34M
1-Year Change
256.50%
Ranking
Category
Stock Price
$3.63
Market Cap Chart
Since the IPO on October 2, 2020, C4 Therapeutics's market cap has decreased from $772.72M to $399.96M, a decrease of -48.24%. That is a compound annual growth rate of -11.07%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 13, 2026 | 405.47M | 119.04% |
| Dec 31, 2025 | 185.11M | -27.16% |
| Dec 31, 2024 | 254.12M | -8.73% |
| Dec 29, 2023 | 278.44M | -3.60% |
| Dec 30, 2022 | 288.85M | -81.55% |
| Dec 31, 2021 | 1.57B | 9.83% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Oct 2, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Larimar Therapeutics | 425.92M |
| Invivyd | 415.72M |
| Verastem | 414.76M |
| Monopar Therapeutics | 411.57M |
| Century Therapeutics | 411.21M |
| Enanta Pharmaceuticals | 407.14M |
| Benitec Biopharma | 399.07M |
| Rocket Pharmaceuticals | 393.10M |